How much did UbiVac raise?

UbiVac raised $80,000 in a funding round on August 2, 2026.

Where is UbiVac based and how big is it?

UbiVac is based in Portland, Oregon, United States. Fundz records about 14 employees.

Who are the decision-makers at UbiVac?

Fundz holds 1 contact at UbiVac. Names and contact details are shown to Fundz members.

Ubivac reported raising $80,000 in an initial SEC Form D filing

PRIVATEAug 27, 2026

Amount Raised

$80,000

$80,000 sold, per SEC Form D (first sale Aug 2, 2026)

Round Type

Venture

PortlandBiotechnologyHealthcare

Quick answer

UbiVac raised $80,000 in a funding round, dated August 2, 2026. UbiVac is based in Portland, Oregon, United States.

How much did UbiVac raise?: UbiVac raised $80,000 in a funding round on August 2, 2026.
What does UbiVac do?: UbiVac has unique and disruptive immune educating and activating vaccine technology.
Where is UbiVac based and how big is it?: UbiVac is based in Portland, Oregon, United States. Fundz records about 14 employees.
Who are the decision-makers at UbiVac?: Fundz holds 1 contact at UbiVac. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as UbiVac that raised within 45 days of this round, from Fundz verified event records.

Tempest Therapeutics raised $7.5M on September 15, 2026.
Lexaria Bioscience raised $113K on September 9, 2026.
Korsana Biosciences raised $380M (Post-IPO Equity) on September 8, 2026.
CytoDyn raised $17M on September 1, 2026.
Tenon Medical raised $4.3M (Series A) on August 31, 2026.
Corvex Legacy Holdings raised $33M on August 31, 2026.

Who to call at UbiVac, and when

A new round usually means UbiVac is about to hire and buy. The teams that reach out first get the meeting.

An alert the day UbiVac raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at UbiVac, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at UbiVac. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

UbiVac

Location

18183 S.W. BOONES FERRY ROAD

Portland, Oregon, United States

About

UbiVac has unique and disruptive immune educating and activating vaccine technology. UbiVac’s lead agent, DPV-001, contains the newly discovered non-mutated shared cancer neoantigens and more than 300 antigens for the majority of patients with adenocarcinoma or squamous cell cancers. Due to its unique platform vaccine technology, novel targets are being discovered that might be used for ADC, CAR-T/NK, and TCR gene therapy. UbiVac postulates that by applying machine learning, artificial intelligence, and generative adversarial networks to the analysis of the extensive monitoring data from these ongoing first-in-human trials, new insights will allow future trials to tailor treatment regimens and further improve outcomes of patients with cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment UbiVac raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contacts3 people are listed at UbiVac. We don't have their email yet.See plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for UbiVac's next move

See what Strategic adds

UbiVac raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.